CRISPR-AI Integration and Screening Services

We implement and fine-tune state-of-the-art models (e.g., CRISPR-Net, DeepCRISPR) to design high-specificity guide RNAs. Our systems predict on-target efficiency and off-target effects with >90% accuracy, validated against public datasets like CRISPR-Cas9 screen repositories. This reduces experimental iteration cycles by up to 70%.

Our custom computer vision pipelines automate the quantification of complex cellular phenotypes from microscopy images. We deploy models trained on domain-specific data to extract features, classify hits, and identify subtle morphological changes, turning terabytes of image data into structured, queryable insights in hours.

We build multimodal AI systems that correlate CRISPR screening hits with transcriptomic, proteomic, and epigenomic data. Using graph neural networks, we model gene regulatory networks and pathway interactions to prioritize targets and elucidate mechanism of action, providing a systems-level view of gene function.

We engineer robust Bio-AI Data Pipeline and MLOps Engineering for your CRISPR workflows. This includes version-controlled model registries, automated data validation, and containerized deployment to on-premise HPC or cloud, ensuring every experiment and prediction is fully reproducible and audit-ready for regulatory submission.

We architect agentic AI systems that analyze screening results, propose follow-up experiment designs (e.g., combinatorial knockouts, dose-response), and automatically generate protocols for integrated lab robotics. This creates a self-improving R&D cycle, continuously refining hypotheses and maximizing information gain per experiment.

Our development process embeds principles from Bio-AI Regulatory Compliance and Validation. We implement rigorous model validation suites, maintain comprehensive data lineage tracking, and generate audit trails for all AI-driven decisions, ensuring your platform meets standards for eventual diagnostic or therapeutic application.